Our findings suggest that the decreased ability of pregnant women with GDM to compensate for oxidative stress was manifested as increased insulin resistance, reduced insulin sensitivity, and β-cell dysfunction, all of which may play important roles in GDM. This evidence concerns the gene INS and gestational diabetes.